Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double-blind Ascending-dose Placebo-controlled Study of N-desmethylclobazam in Patients With Peripheral Neuropathic Pain

NCT04480164 is registered in ClinicalTrials.gov with Besson Marie as lead sponsor.

NCT NCT04480164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04480164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double-blind Ascending-dose Placebo-controlled Study of N-desmethylclobazam in Patients With Peripheral Neuropathic Pain
Lead sponsor
Besson Marie
Phase
Phase 2
Overall status
Suspended
Start date
June 24, 2020
Completion date
May 31, 2023
Enrollment
76 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathic pain